Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 20 April, 2024|Author: Getaka | Social: X Twitter Profile
Stock Ticker - BSE: 506285 | NSE: BAYERCROP

Fundamental Analysis of Bayer CropScience Ltd

Basic Stock Data

Last Updated: April 19, 2024, 8:21 pm

Market Cap 25,703 Cr.
Current Price 5,717
High / Low6,202/4,028
Stock P/E32.1
Book Value 697
Dividend Yield2.27 %
ROCE33.7 %
ROE25.9 %
Face Value 10.0

Data Source:

Competitors of Bayer CropScience Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Sumitomo Chemical India Ltd 20,043 Cr. 401455/33660.2 50.60.30 %30.2 %23.4 % 10.0
Bhagiradha Chemicals & Industries Ltd 1,953 Cr. 1,8892,008/1,10088.8 3080.21 %22.0 %18.4 % 10.0
Adarsh Plant Protect Ltd 25.4 Cr. 25.635.7/15.679.4 1.080.00 %5.44 %15.6 % 10.0
Best Agrolife Ltd 1,495 Cr. 6321,374/4548.77 2980.47 %34.4 %44.8 % 10.0
PI Industries Ltd (PIIND) 56,432 Cr. 3,7154,040/3,01535.4 5260.27 %21.7 %18.5 % 1.00
Industry Average15,989.68 Cr1,332.5254.51236.740.25%22.75%24.14%8.20

Quarterly Result

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Operating Profit106833222226620139523885206425305128
OPM %12%11%23%16%7%21%24%16%8%21%24%19%13%
Other Income182215146816141411624211615
Profit before tax10680320220118190382229184195406306124
Tax %143%22%21%30%28%19%21%29%27%19%19%27%25%
Net Profit-45622541548515330316313415832822393
EPS in Rs-10.0413.7756.4534.2918.8733.9867.3336.1829.9335.2773.0949.6020.72

Last Updated: April 10, 2024, 6:20 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: April 5, 2024, 8:11 am

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Operating Profit2543624195164354144104837268128129241,063
OPM %11%13%13%14%16%15%15%15%20%19%17%18%20%
Other Income-141,242918882703951-646911216875
Profit before tax2041,5634415744824484044805837948479901,031
Tax %32%26%34%33%35%35%26%30%19%38%24%23%
Net Profit1391,162290383315291300337474493645758803
EPS in Rs35.19294.1179.06104.5989.1382.3187.4198.18105.58109.72143.58168.71178.68
Dividend Payout %12%2%7%20%19%21%21%18%24%105%104%77%

Profit & Loss Yearly Chart

YoY Net Profit Growth

YoY Net Profit Growth (%)735.97%-75.04%32.07%-17.75%-7.62%3.09%12.33%40.65%4.01%30.83%17.52%
Change in YoY Net Profit Growth (%)0.00%-811.01%107.11%-49.82%10.14%10.71%9.24%28.32%-36.64%26.82%-13.31%


Compounded Sales Growth
10 Years:7%
5 Years:14%
3 Years:13%
Compounded Profit Growth
10 Years:9%
5 Years:18%
3 Years:6%
Stock Price CAGR
10 Years:14%
5 Years:5%
3 Years:1%
1 Year:30%
Return on Equity
10 Years:20%
5 Years:22%
3 Years:23%
Last Year:26%

Last Updated: April 16, 2024, 6:02 pm

Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital40403737353534344545454545
Other Liabilities1,0484846457405977697561,3101,2621,6631,7421,8932,018
Total Liabilities1,8412,4152,3872,7732,4372,8252,5353,5493,8364,2394,3534,6795,214
Fixed Assets248219228322290342334440468425468462543
Other Assets1,5802,0661,9392,4222,0622,4102,1643,0623,2703,6863,7494,0664,621
Total Assets1,8412,4152,3872,7732,4372,8252,5353,5493,8364,2394,3534,6795,214

Reserves and Borrowings Chart

Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 107138282200206157121433666687216609
Cash from Investing Activity 88427-29048516-838-113-2976483
Cash from Financing Activity -128-21-480-42-590-73-581-158-148-556-703-613
Net Cash Flow67544-488644-36776-421162489138-42479

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow254.00362.00419.00516.00435.00414.00410.00483.00724.00786.00726.00850.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days424447575372898173657769
Inventory Days1281069885169178175294206226235268
Days Payable67425140526767164101142127129
Cash Conversion Cycle10310894102171184197211177149185208
Working Capital Days97988539210413411677628789
ROCE %34%29%24%31%25%23%22%25%30%31%31%34%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
No. of Shareholders65,28565,09362,32162,17860,23057,76057,89657,04857,25348,40445,32946,907

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Mirae Asset Large & Midcap Fund792,9541.33449.55
Nippon India Small Cap Fund531,4600.65301.3
Mirae Asset Midcap Fund510,0841.99289.18
Aditya Birla Sun Life ELSS Tax Saver Fund392,8961.48222.75
Aditya Birla Sun Life Frontline Equity Fund329,4350.71186.77
Nippon India Growth Fund303,5120.7172.07
HSBC Midcap Fund294,9591.72167.22
Aditya Birla Sun Life MNC Fund - Div280,9764.49159.3
Aditya Birla Sun Life MNC Fund - Gr280,9764.49159.3
Kotak Flexicap Fund - Regular Plan215,0000.27121.89

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
Basic EPS (Rs.)168.71143.58109.72105.5878.46
Diluted EPS (Rs.)168.71143.58109.72105.5878.46
Cash EPS (Rs.)186.57158.08126.19120.22111.05
Book Value[Excl.RevalReserv]/Share (Rs.)604.03562.20568.00572.94649.79
Book Value[Incl.RevalReserv]/Share (Rs.)604.03562.20568.00572.94649.79
Dividend / Share (Rs.)130.00150.00115.0025.0018.00
Revenue From Operations / Share (Rs.)1144.701054.43949.06803.88923.41
PBDIT / Share (Rs.)220.07192.81194.99176.48155.74
PBIT / Share (Rs.)202.36178.44178.62161.94142.97
PBT / Share (Rs.)220.51188.60176.95129.87139.94
Net Profit / Share (Rs.)168.86143.72109.82105.6898.28
PBDIT Margin (%)19.2218.2820.5421.9516.86
PBIT Margin (%)17.6716.9218.8220.1415.48
PBT Margin (%)19.2617.8818.6416.1515.15
Net Profit Margin (%)14.7513.6311.5713.1410.64
Return on Networth / Equity (%)27.9525.5619.3318.4415.12
Return on Capital Employeed (%)31.3129.7430.0526.9620.76
Return On Assets (%)16.2014.8211.6312.379.49
Asset Turnover Ratio (%)
Current Ratio (X)
Quick Ratio (X)
Inventory Turnover Ratio (X)1.391.822.171.651.71
Dividend Payout Ratio (NP) (%)74.09104.47104.8221.4137.82
Dividend Payout Ratio (CP) (%)67.0694.9891.2218.8233.47
Earning Retention Ratio (%)25.91-4.47-4.8278.5962.18
Cash Earning Retention Ratio (%)32.945.028.7881.1866.53
Interest Coverage Ratio (X)44.3167.1169.4857.4251.37
Interest Coverage Ratio (Post Tax) (X)30.3546.4939.7344.8233.41
Enterprise Value (Cr.)17307.3021584.0322612.2014460.2914456.49
EV / Net Operating Revenue (X)3.374.565.314.014.56
EV / EBITDA (X)17.5224.9325.8318.2527.06
MarketCap / Net Operating Revenue (X)3.544.735.594.304.75
Retention Ratios (%)25.90-4.47-4.8278.5862.17
Price / BV (X)6.708.869.346.046.75
Price / Net Operating Revenue (X)3.544.735.594.304.75

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 5926.33

The stock is undervalued by 3.66% compared to the current price ₹5717

Calculation basis:

  • Fair value = (P/E Ratio * (Return on Equity / 100) * Book Value) * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

*Investments are subject to market risks

Strength and Weakness

  1. The stock has a high average ROCE of 28.25%, which is a positive sign.
  2. The company has higher reserves (2,106.62 cr) compared to borrowings (19.38 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (3.08 cr) and profit (480.69 cr) over the years.
  1. The stock has a high average Working Capital Days of 82.50, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 157.42, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bayer CropScience Ltd:
    1. Net Profit Margin: 14.75%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 31.31% (Industry Average ROCE: 16.18%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 27.95% (Industry Average ROE: 14.23%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 30.35
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.18
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 32.1 (Industry average Stock P/E: 16.64)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: N/A
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating: ★★★★︎☆

About the Company

Bayer Cropscience Ltd. is a Public Limited Listed company incorporated on 09/09/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24210MH1958PLC011173 and registration number is 011173. Currently Company is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 4734.40 Cr. and Equity Capital is Rs. 44.90 Cr. for the Year ended 31/03/2022.
Agro Chemicals/PesticidesBayer House, Central Avenue, Mumbai Maharashtra
NamePosition Held
Mr. Pankaj PatelChairman(NonExe.&Ind.Director)
Mr. Duraiswami NarainVC & Mng.Director & CEO
Mr. Simon BritschExecutive Director & CFO
Mr. Brian NaberNon Exe.Non Ind.Director
Dr. Thomas HoffmannNon Exe.Non Ind.Director
Mr. Simon WiebuschWhole Time Director
Dr. Harsh Kumar BhanwalaInd. Non-Executive Director
Ms. Ketaki BhagwatiInd. Non-Executive Director
Mr. Sekhar NatarajanInd. Non-Executive Director

Bayer Cropscience Ltd. Share Price Update

Share PriceValue
Previous Day₹5,550.05


What is the latest fair value of Bayer CropScience Ltd?

The latest fair value of Bayer CropScience Ltd is 5926.33.

What is the Market Cap of Bayer CropScience Ltd?

The Market Cap of Bayer CropScience Ltd is 25,703 Cr..

What is the current Stock Price of Bayer CropScience Ltd as on 19 April 2024?

The current stock price of Bayer CropScience Ltd as on 19 April 2024 is 5,717.

What is the High / Low of Bayer CropScience Ltd stocks in FY 2024?

In FY 2024, the High / Low of Bayer CropScience Ltd stocks is ₹6,202/4,028.

What is the Stock P/E of Bayer CropScience Ltd?

The Stock P/E of Bayer CropScience Ltd is 32.1.

What is the Book Value of Bayer CropScience Ltd?

The Book Value of Bayer CropScience Ltd is 697.

What is the Dividend Yield of Bayer CropScience Ltd?

The Dividend Yield of Bayer CropScience Ltd is 2.27 %.

What is the ROCE of Bayer CropScience Ltd?

The ROCE of Bayer CropScience Ltd is 33.7 %.

What is the ROE of Bayer CropScience Ltd?

The ROE of Bayer CropScience Ltd is 25.9 %.

What is the Face Value of Bayer CropScience Ltd?

The Face Value of Bayer CropScience Ltd is 10.0.

About the Author

Author Avatar

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Bayer CropScience Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE